STERIS (STE) Revenue — Quarter Ended Jun 30, 2023
Revenue for the quarter declined compared to the immediately preceding quarter but rose compared to the same quarter one year earlier. This mixed performance reflects a reversal of the sequential gain seen in the prior period while maintaining year-over-year growth.
Key takeaway
Quarter ended Jun 30, 2023 · FY2024 Q1
Revenue for the quarter declined compared to the immediately preceding quarter but rose compared to the same quarter one year earlier. This mixed performance reflects a reversal of the sequential gain seen in the prior period while maintaining year-over-year growth.
Financial snapshot
Reported revenue, sequential change, year-over-year change, and trailing four-quarter revenue.
Quarter revenue
$1.2B
Revenue reported for this quarter.
Quarter-over-quarter
-7.6%
Change from the immediately preceding quarter.
Year-over-year
+12.5%
Change from the comparable year-ago quarter.
Trailing four quarters
$5B
Sum of the latest four reported quarters.
Quarterly revenue trend
The latest four reported quarters with year-over-year comparisons.
| Period ended | Revenue | Year-over-year change |
|---|---|---|
| Sep 30, 2022 | $1.3B | +9.1% |
| Dec 31, 2022 | $1.2B | +0.6% |
| Mar 31, 2023 | $1.3B | +5.8% |
| Jun 30, 2023 | $1.2B | +12.5% |
Revenue performance
The reported revenue decreased from the prior quarter, ending a period of sequential expansion. However, it remained above the level achieved in the same quarter last year.
Quarterly comparison
Compared with the immediately preceding quarter, revenue was lower. In contrast, revenue was higher when measured against the same quarter one year earlier.
What to watch
Monitor whether revenue can regain the sequential growth trajectory while sustaining the year-over-year improvement.